Alexander J. Kallen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexander J. Kallen has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Arjun Srinivasan
5 shared publicationsPriti R. Patel
5 shared publicationsJean Patel
3 shared publicationsSusan E. Beekmann
Univ Iowa, Carver Coll Med, Iowa City, IA USA
3 shared publicationsBrandi Limbago
Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA
2 shared publicationsGhinwa Dumyati
New York Emerging Infections Program and University of Rochester Medical Center, Rochester
2 shared publications
Latest Publications
- 6 April 2018
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 67 (13) , 396-401
Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms — United States, 2006–2017
CDC evaluates approaches to limit the spread of emerging forms of antibiotic resistance in health care settings.
- 6 April 2018
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 67 (13) , 396-401
Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms — United States, 2006–2017
CDC evaluates approaches to limit the spread of emerging forms of antibiotic resistance in health care settings.
- Top Cited PapersOpen Access
- 13 October 2015
- Published by American Medical Association (AMA) in JAMA
- Vol. 314 (14) , 1479-1487
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Carbapenem-resistant Enterobacteriaceae (CRE) are a worldwide clinical and public health problem. These multidrug-resistant organisms cause infections associated with high mortality and limited treatment options, and are increasingly recognized as an important cause of health care–associated infections.1-5 In the United States, much of the initial dissemination of CRE can be attributed to organisms producing the Klebsiella pneumoniae carbapenemase, a type of β-lactamase enzyme that confers resistance to carbapenem antimicrobials.
- 13 October 2015
- Published by American Medical Association (AMA) in JAMA
- Vol. 314 (14) , 1479-1487
Top Cited PapersOpen AccessEpidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Carbapenem-resistant Enterobacteriaceae (CRE) are a worldwide clinical and public health problem. These multidrug-resistant organisms cause infections associated with high mortality and limited treatment options, and are increasingly recognized as an important cause of health care–associated infections.1-5 In the United States, much of the initial dissemination of CRE can be attributed to organisms producing the Klebsiella pneumoniae carbapenemase, a type of β-lactamase enzyme that confers resistance to carbapenem antimicrobials.
- 1 December 2014
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 35 (12) , 1531-1534
Prevalence of and Risk Factors for Vancomycin-Resistant Staphylococcus aureus Precursor Organisms in Southeastern Michigan
We assessed for vancomycin-resistantStaphylococcus aureus(VRSA) precursor organisms in southeastern Michigan, an area known to have VRSA. The prevalence was 2.5% (pSK41-positive methicillin-resistantS. aureus, 2009–2011) and 1.5% (Inc18-positive vancomycin-resistantEnterococcus, 2006–2013); Inc18 prevalence significantly decreased after 2009 (3.7% to 0.82%). Risk factors for pSK41 included intravenous vancomycin exposure.Infect Control Hosp Epidemiol2014;35(12):1531–1534
- 1 December 2014
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 35 (12) , 1531-1534
Prevalence of and Risk Factors for Vancomycin-Resistant Staphylococcus aureus Precursor Organisms in Southeastern Michigan
We assessed for vancomycin-resistantStaphylococcus aureus(VRSA) precursor organisms in southeastern Michigan, an area known to have VRSA. The prevalence was 2.5% (pSK41-positive methicillin-resistantS. aureus, 2009–2011) and 1.5% (Inc18-positive vancomycin-resistantEnterococcus, 2006–2013); Inc18 prevalence significantly decreased after 2009 (3.7% to 0.82%). Risk factors for pSK41 included intravenous vancomycin exposure.Infect Control Hosp Epidemiol2014;35(12):1531–1534
- 3 April 2014
- Vol. 41 (1) , 37-40
Infection control and bloodstream infection prevention: the perspective of patients receiving hemodialysis.
Patients on hemodialysis, particularly those dialyzed through central lines, are at risk of acquiring bloodstream infections. Strategies to prevent bloodstream infections in patients on dialysis include educating patients about infection prevention, although patients' perspectives on this topic are not known. During focus groups conducted to explore these issues, patients reported that education on infection prevention should begin early in the process of dialysis, and that patients should be actively engaged as partners in infection prevention.
- 3 April 2014
- Vol. 41 (1) , 37-40
Infection control and bloodstream infection prevention: the perspective of patients receiving hemodialysis.
Patients on hemodialysis, particularly those dialyzed through central lines, are at risk of acquiring bloodstream infections. Strategies to prevent bloodstream infections in patients on dialysis include educating patients about infection prevention, although patients' perspectives on this topic are not known. During focus groups conducted to explore these issues, patients reported that education on infection prevention should begin early in the process of dialysis, and that patients should be actively engaged as partners in infection prevention.
- 1 December 2011
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 32 (12) , 1149-1157
Transmission of 2009 Pandemic Influenza A (H1N1) Virus among Healthcare Personnel—Southern California, 2009
Objective.: In April 2009, 2009 pandemic influenza A (H1N1) (hereafter, pH1N1) virus was identified in California, which caused widespread illness throughout the United States. We evaluated pH1N1 transmission among exposed healthcare personnel (HCP) and assessed the use and effectiveness of personal protective equipment (PPE) early in the outbreak.Design.: Cohort study.Setting.: Two hospitals and 1 outpatient clinic in Southern California during March 28-April 24, 2009.Participants.: Sixty-three HCP exposed to 6 of the first 8 cases of laboratory-confirmed pH1N1 in the United States.Methods.: Baseline and follow-up questionnaires were used to collect demographic, epidemiologic, and clinical data. Paired serum samples were obtained to test for pH1N1-specific antibodies by microneutralization and hemagglutination-inhibition assays. Serology results were compared with HCP work setting, role, and self-reported PPE use.Results.: Possible healthcare-associated pH1N1 transmission was identified in 9 (14%) of 63 exposed HCP; 6 (67%) of 9 seropositive HCP had asymptomatic infection. The highest attack rates occurred among outpatient HCP (6/19 [32%]) and among allied health staff (eg, technicians; 8/33 [24%]). Use of mask or N95 respirator was associated with remaining seronegative (P = .047). Adherence to PPE recommendations for preventing transmission of influenza virus and other respiratory pathogens was inadequate, particularly in outpatient settings.Conclusions.: pH1N1 transmission likely occurred in healthcare settings early in the pandemic associated with inadequate PPE use. Organizational support for a comprehensive approach to infectious hazards, including infection prevention training for inpatient- and outpatient-based HCP, is essential to improve HCP and patient safety.
- 1 December 2011
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 32 (12) , 1149-1157
Transmission of 2009 Pandemic Influenza A (H1N1) Virus among Healthcare Personnel—Southern California, 2009
Objective.: In April 2009, 2009 pandemic influenza A (H1N1) (hereafter, pH1N1) virus was identified in California, which caused widespread illness throughout the United States. We evaluated pH1N1 transmission among exposed healthcare personnel (HCP) and assessed the use and effectiveness of personal protective equipment (PPE) early in the outbreak.Design.: Cohort study.Setting.: Two hospitals and 1 outpatient clinic in Southern California during March 28-April 24, 2009.Participants.: Sixty-three HCP exposed to 6 of the first 8 cases of laboratory-confirmed pH1N1 in the United States.Methods.: Baseline and follow-up questionnaires were used to collect demographic, epidemiologic, and clinical data. Paired serum samples were obtained to test for pH1N1-specific antibodies by microneutralization and hemagglutination-inhibition assays. Serology results were compared with HCP work setting, role, and self-reported PPE use.Results.: Possible healthcare-associated pH1N1 transmission was identified in 9 (14%) of 63 exposed HCP; 6 (67%) of 9 seropositive HCP had asymptomatic infection. The highest attack rates occurred among outpatient HCP (6/19 [32%]) and among allied health staff (eg, technicians; 8/33 [24%]). Use of mask or N95 respirator was associated with remaining seronegative (P = .047). Adherence to PPE recommendations for preventing transmission of influenza virus and other respiratory pathogens was inadequate, particularly in outpatient settings.Conclusions.: pH1N1 transmission likely occurred in healthcare settings early in the pandemic associated with inadequate PPE use. Organizational support for a comprehensive approach to infectious hazards, including infection prevention training for inpatient- and outpatient-based HCP, is essential to improve HCP and patient safety.
- 1 November 2011
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 32 (11) , 1144-1146
Intolerance of Chlorhexidine as a Skin Antiseptic in Patients Undergoing Hemodialysis
Intolerance of Chlorhexidine as a Skin Antiseptic in Patients Undergoing Hemodialysis - Volume 32 Issue 11 - Alexander J. Kallen, Priti R. Patel, Sally Hess
- 1 November 2011
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 32 (11) , 1144-1146
Intolerance of Chlorhexidine as a Skin Antiseptic in Patients Undergoing Hemodialysis
Intolerance of Chlorhexidine as a Skin Antiseptic in Patients Undergoing Hemodialysis - Volume 32 Issue 11 - Alexander J. Kallen, Priti R. Patel, Sally Hess
- 28 August 2011
- Published by Wiley in Seminars in Dialysis
- Vol. 24 (5) , 533-539
Decolonization to Prevent Infections with Staphylococcus aureus in Patients Undergoing Hemodialysis: A Review of Current Evidence
Staphylococcus aureus infections remain common in patients undergoing hemodialysis, and the consequences of these infections are potentially severe. Although a number of evidence‐based practices have been shown to decrease the healthcare‐associated infections that this organism can cause, many questions remain about the utility of decolonization as a mechanism to prevent these infections. This brief review describes the current epidemiology of S. aureus infections in patients undergoing hemodialysis and reviews the evidence surrounding decolonization as an infection prevention strategy.
- 28 August 2011
- Published by Wiley in Seminars in Dialysis
- Vol. 24 (5) , 533-539
Decolonization to Prevent Infections with Staphylococcus aureus in Patients Undergoing Hemodialysis: A Review of Current Evidence
Staphylococcus aureus infections remain common in patients undergoing hemodialysis, and the consequences of these infections are potentially severe. Although a number of evidence‐based practices have been shown to decrease the healthcare‐associated infections that this organism can cause, many questions remain about the utility of decolonization as a mechanism to prevent these infections. This brief review describes the current epidemiology of S. aureus infections in patients undergoing hemodialysis and reviews the evidence surrounding decolonization as an infection prevention strategy.
- 1 November 2010
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 31 (S1) , S51-S54
Current Epidemiology of Multidrug-Resistant Gram-Negative Bacilli in the United States
Gram-negative bacilli are an important cause of infection in healthcare and community settings. Antimicrobial resistance, including resistance to multiple antimicrobial classes, is an ongoing problem among gram-negative bacilli. This synopsis reviews the incidence of multidrug resistance among gram-negative bacilli in the United States and describes emerging issues in their epidemiology.
- 1 November 2010
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 31 (S1) , S51-S54
Current Epidemiology of Multidrug-Resistant Gram-Negative Bacilli in the United States
Gram-negative bacilli are an important cause of infection in healthcare and community settings. Antimicrobial resistance, including resistance to multiple antimicrobial classes, is an ongoing problem among gram-negative bacilli. This synopsis reviews the incidence of multidrug resistance among gram-negative bacilli in the United States and describes emerging issues in their epidemiology.
- 11 August 2010
- Published by American Medical Association (AMA) in JAMA
- Vol. 304 (6) , 641-647
Health Care–Associated Invasive MRSA Infections, 2005-2008
Research from JAMA — Health Care–Associated Invasive MRSA Infections, 2005-2008
- 11 August 2010
- Published by American Medical Association (AMA) in JAMA
- Vol. 304 (6) , 641-647
Health Care–Associated Invasive MRSA Infections, 2005-2008
Research from JAMA — Health Care–Associated Invasive MRSA Infections, 2005-2008